Patents by Inventor Yoshihiko Kawaguchi

Yoshihiko Kawaguchi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10499801
    Abstract: An endoscope reprocessor includes a concentration sensor including a concave section in which a sensing section is housed and a permeable membrane configured to cover the concave section, a pressure resistant container in which the concentration sensor is housed, a medicinal-solution lead-in section configured to introduce a medicinal solution into the pressure resistant container, and a pressure adjusting section configured to adjust pressure such that an internal pressure of the concave section is low compared with an internal pressure of the pressure resistant container.
    Type: Grant
    Filed: November 9, 2017
    Date of Patent: December 10, 2019
    Assignees: OLYMPUS CORPORATION, HORIBA Advanced Techno, Co., Ltd.
    Inventors: Hideto Onishi, Yoshihiko Kawaguchi, Satoko Kai
  • Patent number: 10499800
    Abstract: An endoscope reprocessor includes a concentration sensor including a concave section in which a sensing section is housed and a permeable membrane configured to cover the concave section, a medicinal solution tank, to an inside of which at least the permeable membrane is exposed and on the inside of which a disinfection solution is stored, and a heating section configured to heat at least the permeable membrane.
    Type: Grant
    Filed: November 9, 2017
    Date of Patent: December 10, 2019
    Assignees: OLYMPUS CORPORATION, HORIBA Advanced Techno, Co., Ltd.
    Inventors: Hideto Onishi, Hiromasa Akahori, Yumiko Awau, Akihisa Ogawa, Shintaro Suzuki, Yoshihiko Kawaguchi, Satoko Kai
  • Patent number: 10502703
    Abstract: A main object of the present invention is to provide a membrane covered type peracetic acid concentration meter that can prevent various common problems, including problems that occur in the event of an internal solution leak into a sample solution. The membrane covered type peracetic acid concentration meter adapted to measure the concentration of peracetic acid in the sample solution includes: a membrane that allows peracetic acid to permeate; and the internal solution that dissolves peracetic acid having permeated the membrane. In addition, as the internal solution, a buffer solution having a buffering action on hydrogen ion concentration is used.
    Type: Grant
    Filed: June 2, 2015
    Date of Patent: December 10, 2019
    Assignee: HORIBA Advanced Techno, Co., Ltd.
    Inventors: Yoshihiko Kawaguchi, Satoko Kai
  • Publication number: 20180064325
    Abstract: An endoscope reprocessor includes a concentration sensor including a concave section in which a sensing section is housed and a permeable membrane configured to cover the concave section, a pressure resistant container in which the concentration sensor is housed, a medicinal-solution lead-in section configured to introduce a medicinal solution into the pressure resistant container, and a pressure adjusting section configured to adjust pressure such that an internal pressure of the concave section is low compared with an internal pressure of the pressure resistant container.
    Type: Application
    Filed: November 9, 2017
    Publication date: March 8, 2018
    Applicants: OLYMPUS CORPORATION, HORIBA Advanced Techno, Co., Ltd.
    Inventors: Hideto ONISHI, Yoshihiko KAWAGUCHI, Satoko KAI
  • Publication number: 20180064324
    Abstract: An endoscope reprocessor includes a concentration sensor including a concave section in which a sensing section is housed and a permeable membrane configured to cover the concave section, a medicinal solution tank, to an inside of which at least the permeable membrane is exposed and on the inside of which a disinfection solution is stored, and a heating section configured to heat at least the permeable membrane.
    Type: Application
    Filed: November 9, 2017
    Publication date: March 8, 2018
    Applicants: OLYMPUS CORPORATION, HORIBA Advanced Techno, Co., Ltd.
    Inventors: Hideto ONISHI, Hiromasa AKAHORI, Yumiko AWAU, Akihisa OGAWA, Shintaro SUZUKI, Yoshihiko KAWAGUCHI, Satoko KAI
  • Publication number: 20150346139
    Abstract: A main object of the present invention is to provide a membrane covered type peracetic acid concentration meter that can prevent various common problems, including problems that occur in the event of an internal solution leak into a sample solution. The membrane covered type peracetic acid concentration meter adapted to measure the concentration of peracetic acid in the sample solution includes: a membrane that allows peracetic acid to permeate; and the internal solution that dissolves peracetic acid having permeated the membrane. In addition, as the internal solution, a buffer solution having a buffering action on hydrogen ion concentration is used.
    Type: Application
    Filed: June 2, 2015
    Publication date: December 3, 2015
    Inventors: Yoshihiko Kawaguchi, Satoko Kai
  • Patent number: 7244577
    Abstract: A novel receptor, “LDL-receptor-related protein-5” (“LRP-5”), is provided, along with encoding nucleic acid. The gene is associated with type 1 diabetes (insulin dependent diabetes mellitus), and experimental evidence provides indication that it is the IDDM susceptibility gene IDDM4. In various aspects the invention provides nucleic acid, including coding sequences, oligonucleotide primers and probes, polypeptides, pharmaceutical compositions, methods of diagnosis or prognosis, and other methods relating to and based on the gene, including methods of treatment of diseases in which the gene may be implicated, including autoimmune diseases, such as glomerulonephritis, diseases and disorders involving disruption of endocytosis and/or antigen presentation, diseases and disorders involving cytokine clearance and/or inflammation, viral infection, elevation of free fatty acids or hypercholesterolemia, osteoporosis, Alzheimer's disease, and diabetes.
    Type: Grant
    Filed: December 31, 2002
    Date of Patent: July 17, 2007
    Assignee: Merck & Co., Inc.
    Inventors: John A. Todd, John W. Hess, Charles T. Caskey, Roger D Cox, David Gerhold, Holly Hammond, Patricia Hey, Yoshihiko Kawaguchi, Tony R. Merriman, Michael L. Metzker, Yusuke Nakagawa, Michael S. Phillips, Rebecca C. J. Twells
  • Publication number: 20030181660
    Abstract: A novel receptor, “LDL-receptor-related protein-3” (“LRP-3”), is provided, along with encoding nucleic acid. The gene is associated with type 1 diabetes (insulin dependent diabetes mellitus), and experimental evidence provides indication that it is the IDDM susceptibility gene IDDM4. In various aspects the invention provides nucleic acid, including coding sequences, oligonucleotide primers and probes, polypeptides, pharmaceutical compositions, methods of diagnosis or prognosis, and other methods relating to and based on the gene, including methods of treatment of diseases in which the gene may be implicated, including autoimmune diseases, such as glomerulonephritis, diseases and disorders involving disruption of endocytosis and/or antigen presentation, diseases and disorders involving cytokine clearance and/or inflammation, viral infection, elevation of free fatty acids or hypercholesterolemia, osteoporosis, Alzheimer's disease, and diabetes.
    Type: Application
    Filed: December 31, 2002
    Publication date: September 25, 2003
    Applicant: The WellcomeTrust Limited as Trustee for the Wellcome Trust
    Inventors: John A. Todd, John W. Hess, Charles T. Caskey, Roger D. Cox, David Gerhold, Holly Hammond, Patricia Hey, Yoshihiko Kawaguchi, Tony R. Merriman, Michael L. Metzker, Yusuke Nakagawa, Michael S. Phillips, Rebecca C.J. Twells
  • Patent number: 6555654
    Abstract: A novel receptor, “LDL-receptor related protein-3” (“LRP-3”), is provided, along with encoding nucleic acid. The gene is associated with type 1 diabetes (insulin dependent diabetes mellitus), and experimental evidence provides indication that it is the IDDM susceptibility gene IDDM4. In various aspects the invention provides nucleic acid, including coding sequences, oligonucleotide primers and probes, polypeptides, pharmaceutical compositions, methods of diagnosis or prognosis, and other methods relating to and based on the gene, including methods of treatment of diseases in which the gene may be implicated, including autoimmune diseases, such as glomerulonephritis, diseases and disorders involving disruption of endocytosis and/or antigen presentation, diseases and disorders involving cytokine clearance and/or inflammation, viral infection, elevation of free fatty acids or hypercholesterolemia, osteoporosis, Alzheimer's disease, and diabetes.
    Type: Grant
    Filed: February 14, 2000
    Date of Patent: April 29, 2003
    Assignee: The Wellcome Trust Limited as Trustee for the Wellcome Trust
    Inventors: John A. Todd, John W. Hess, Charles T. Caskey, Roger D Cox, David Gerhold, Holly Hammond, Patricia Hey, Yoshihiko Kawaguchi, Tony R. Merriman, Michael L. Metzker, Yusuke Nakagawa, Michael S. Phillips, Rebecca C. J. Twells
  • Patent number: 6545137
    Abstract: A novel receptor, “LDL-receptor related protein-3” (“LRP-3”), is provided, along with encoding nucleic acid. The gene is associated with type 1 diabetes (insulin dependent diabetes mellitus), and experimental evidence provides indication that it is the IDDM susceptibility gene IDDM4. In various aspects the invention provides nucleic acid, including coding sequences, oligonucleotide primers and probes, polypeptides, pharmaceutical compositions, methods of diagnosis or prognosis, and other methods relating to and based on the gene, including methods of treatment of diseases in which the gene may be implicated, including autoimmune diseases, such as glomerulonephritis, diseases and disorders involving disruption of endocytosis and/or antigen presentation, diseases and disorders involving cytokine clearance and/or inflammation, viral infection, elevation of free fatty acids or hypercholesterolemia, osteoporosis, Alzheimer's disease, and diabetes.
    Type: Grant
    Filed: April 15, 1998
    Date of Patent: April 8, 2003
    Inventors: John A. Todd, John W. Hess, Charles T. Caskey, Roger D Cox, David Gerhold, Holly Hammond, Patricia Hey, Yoshihiko Kawaguchi, Tony R. Merriman, Michael L. Metzker, Yusuke Nakagawa, Michael S. Phillips, Rebecca C.J. Twells
  • Patent number: 4065419
    Abstract: Rice-bran wax in the amount of 0.1 to 10 parts by weight per 100 parts of elastomer is added to fluoroelastomers to improve the processability of the fluoroelastomer.
    Type: Grant
    Filed: October 15, 1976
    Date of Patent: December 27, 1977
    Inventors: Yoshihiko Kawaguchi, Yoshimi Harada, Makoto Miki, Kanenari Gouda, Masaharu Akiyama, Masayuki Tokura, Jun Kuroha